Swaddling: a systematic review

…, AC Engelberts, MM Boere-Boonekamp, W Kuis… - …, 2007 - publications.aap.org
… were responsible for reviewing the articles, participated in writing the manuscript, and were
involved in the conception and design of the manuscript; and Drs Schulpen and Kuis were …

Preliminary core sets of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis

…, BM Feldman, S Garay, W Kuis… - …, 2003 - academic.oup.com
Objective. To identify preliminary core sets of outcome variables for disease activity and
damage assessment in juvenile systemic lupus erythematosus (JSLE) and juvenile …

Systemic JIA: new developments in the understanding of the pathophysiology and therapy

SJ Vastert, W Kuis, AA Grom - Best Practice & Research Clinical …, 2009 - Elsevier
Systemic juvenile idiopathic arthritis (sJIA) is a rare, systemic inflammatory disease classified
as a subtype of JIA. Besides arthritis, it is characterised by systemic features such as …

[HTML][HTML] Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy

…, A Fischer, EG Davies, W Kuis… - New england journal …, 2002 - Mass Medical Soc
Background X-linked severe combined immunodeficiency due to a mutation in the gene
encoding the common γ (γc) chain is a lethal condition that can be cured by allogeneic stem-cell …

Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells

…, H te Velthuis, BJ Prakken, W Kuis… - Clinical and Vaccine …, 2003 - Am Soc Microbiol
Cytokines secreted by cells of the immune system can alter the behavior and properties of
immune or other cells. At a site of inflammation, sets of cytokines interact with immune cells, …

Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome

SM Houten, W Kuis, M Duran, TJ De Koning… - Nature …, 1999 - nature.com
Hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS; MIM 260920) is an
autosomal recessive disorder characterized by recurrent episodes of fever associated with …

CD4+ CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis

…, F Giannoni, G Rijkers, S Albani, W Kuis… - The journal of …, 2004 - journals.aai.org
This study investigates the role of CD4+ CD25+ regulatory T cells during the clinical course
of juvenile idiopathic arthritis (JIA). Persistent oligoarticular JIA (pers-OA JIA) is a subtype of …

Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study

…, NM Wulffraat, LR Wedderburn, W Kuis… - Annals of the …, 2007 - ard.bmj.com
Background: Juvenile idiopathic arthritis (JIA) consists of a heterogeneous group of disorders
with, for the most part, an unknown immunopathogenesis. Although onset and disease …

Myeloid‐related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease …

…, A Strey, T Vogl, NM Wulffraat, W Kuis… - … : Official Journal of …, 2000 - Wiley Online Library
Objective To analyze which physiologic stimuli induce secretion of myeloid‐related protein
8 (MRP8) and MRP14, two S100 proteins expressed in neutrophils and monocytes, and to …

Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double‐blind, placebo‐controlled, multicenter study

…, NM Wulffraat, JCM Oostveen, W Kuis… - … : Official Journal of …, 1998 - Wiley Online Library
… Patients’ response to sulfasalazine therapy (0) as compared with placebo (W). Response
was defined as improvement in the severity score of joint swelling by 2 grades or a score of 0 …